Bone Biologics Corp (BBLG): Total Assets

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2015-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$5.80M
As of 2025-12-31
$4.44M
As of 2026-06-30
-12.0%
3-year compound annual growth
+14.1%
10-year compound annual growth
$8.50M2011-10-31: $02012-10-31: $5002013-10-31: $3802013-12-31: $87.3K2014-12-31: $3.82M2015-12-31: $1.55M2016-03-31: $4.32M2016-06-30: $2.33M2016-09-30: $771.4K2016-12-31: $701.1K2017-03-31: $1.70M2017-06-30: $868.4K2017-09-30: $1.67M2017-12-31: $795.7K2018-12-31: $1.04M2019-12-31: $30.8K2020-12-31: $02021-12-31: $6.68M2022-12-31: $8.50M2023-12-31: $3.74M2024-12-31: $3.86M2025-12-31: $5.80M$5.80M
2011-10-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$5.80M+50.1%2026-03-02, Balance as of period end
2024-12-31$3.86M+3.3%2026-03-02, Balance as of period end
2023-12-31$3.74M-56.0%2025-02-26, Balance as of period end
2022-12-31$8.50M+27.3%2024-02-21, Balance as of period end
2021-12-31$6.68Mn/a2023-03-30, Balance as of period end
2020-12-31$0-100.0%2021-04-15, Balance as of period end
2019-12-31$30.8K-97.0%2021-04-15, Balance as of period end
2018-12-31$1.04M+30.8%2020-03-30, Balance as of period end
2017-12-31$795.7Kn/a2019-03-29, Balance as of period end
2017-09-30$1.67Mn/a2018-04-02, Balance as of period end
2017-06-30$868.4Kn/a2018-04-02, Balance as of period end
2017-03-31$1.70Mn/a2018-04-02, Balance as of period end
2016-12-31$701.1Kn/a2018-04-02, Balance as of period end
2016-09-30$771.4Kn/a2018-04-02, Balance as of period end
2016-06-30$2.33Mn/a2018-04-02, Balance as of period end
2016-03-31$4.32Mn/a2018-04-02, Balance as of period end
2015-12-31$1.55Mn/c2017-03-30, Balance as of period end
2014-12-31$3.82Mn/m2016-03-28, Balance as of period end
2013-12-31$87.3Kn/a2015-03-31, Balance as of period end
2013-10-31$380-24.0%2014-02-13, Balance as of period end
2012-10-31$500n/a2014-02-13, Balance as of period end
2011-10-31$0n/a2013-01-29, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Orthopedic, Prosthetic & Surgical Appliances & Supplies), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Bone Biologics Corp (BBLG)2025-12-31$5.80M+50.1%
NutriBand Inc. (NTRB)2026-01-31$7.55M+1.0%
Regentis Biomaterials Ltd. (RGNT)2025-12-31$7.62Mn/m
Milestone Scientific Inc. (MLSS)2025-12-31$7.81M-20.3%
Envoy Medical, Inc. (COCH)2025-12-31$8.56M-25.8%
CollPlant Biotechnologies Ltd (CLGN)2025-12-31$10.79M-42.4%
Safe Pro Group Inc. (SPAI)2025-12-31$19.11M+286.2%
Vicarious Surgical Inc. (RBOT)2025-12-31$19.58M-71.1%
LogicMark, Inc. (LGMK)2025-12-31$20.31M+42.8%

Compare BBLG, NTRB, RGNT, MLSS side by side · Screen every company in Orthopedic, Prosthetic & Surgical Appliances & Supplies ↗